Petros Pharma Stock (NASDAQ: PTPI) stock price, news, charts, stock research, profile.
Open | $0.44 |
Close | $0.46 |
Volume / Avg. | 174.87K / 437.01K |
Day Range | 0.43 - 0.48 |
52 Wk Range | 0.39 - 4.74 |
Market Cap | $3.21M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 8.31% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Petros Pharma (NASDAQ:PTPI) through any online brokerage.
Other companies in Petros Pharma’s space includes: Cingulate (NASDAQ:CING), Biofrontera (NASDAQ:BFRI), NovaBay Pharmaceuticals (AMEX:NBY), cbdMD (AMEX:YCBD) and 60 Degrees (NASDAQ:SXTP).
There is no analysis for Petros Pharma.
Petros Pharma has a consensus price target of $4.00.
The stock price for Petros Pharma (NASDAQ: PTPI) is $0.458 last updated June 28, 2024 at 7:26 PM EDT.
There are no upcoming dividends for Petros Pharma.
Petros Pharma’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Petros Pharma.
Petros Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.